News

34 Lives Achieves Milestone: 130 Kidneys Saved for Patients

34 Lives Achieves Milestone: 130 Kidneys Saved for Patients

A Significant Achievement in Kidney Transplants

34 Lives, a pioneering Public Benefit Company, has successfully rescued and transplanted 130 kidneys, marking a major milestone in its mission. This remarkable accomplishment reflects the company's commitment to preventing waste of viable donor kidneys that are often left unused.

The Mission of 34 Lives

Founded in 2022 and based in the Purdue Research Park, this organization is dedicated to the cause of kidney transplants. With a focus on technological innovations, 34 Lives aims to recover about 50% of underutilized donor kidneys, providing hope to patients who are desperately waiting for transplants.

Community and Collaboration

34 Lives has successfully partnered with 17 Organ Procurement Organizations (OPOs) and 15 transplant centers, showcasing the collaborative efforts that play a fundamental role in saving lives. Kathleen St. Jean, co-founder of the organization, has passionately pointed out that every day, approximately 34 patients drop off the transplant waiting list for various reasons, including declining health. The company is determined to reduce this number significantly.

Challenges in Kidney Recovery

According to data from the Organ Procurement and Transplantation Network, the recovery of kidneys that go unused has increased dramatically over the years. In the previous year, nearly 9,275 recovered kidneys were declined for transplantation, showing a 52% rise in nonuse rates since 2016—a concerning trend that has prompted 34 Lives to take action.

Funding and Future Plans

Last September, 34 Lives received a notable grant of $44 million over five years from the Advanced Research Projects Agency for Health (ARPA-H). This funding will facilitate the implementation of the "No Kidney Left Behind" initiative, designed to optimize the viability of donor kidneys through innovative methodologies. With 25 employees at present and aspirations to expand the team, the organization is readjusting its focus for broader coverage and support.

Industry Support and Recognition

Kevin Longino, CEO of the National Kidney Foundation, expressed strong support for 34 Lives, emphasizing its critical role in the kidney care landscape. He highlights the essential innovation that 34 Lives provides, underscoring the increasing need for robust processes in kidney recovery.

About 34 Lives

34 Lives is located in West Lafayette, Indiana, and is dedicated to changing the future of kidney transplants. The firm’s mission emphasizes ensuring that underutilized kidneys receive proper chances for transplantation through strategic planning and innovative solutions.

Frequently Asked Questions

What is the main goal of 34 Lives?

The primary goal of 34 Lives is to recover and transplant kidneys that might otherwise go unused, providing hope to patients on waiting lists.

How many kidneys has 34 Lives rescued?

To date, 34 Lives has successfully rescued 130 kidneys through their innovative processes.

What partnerships has 34 Lives established?

34 Lives has collaborated with 17 Organ Procurement Organizations (OPOs) and 15 transplant centers.

What major funding has 34 Lives received?

In 2024, 34 Lives received a $44 million grant from ARPA-H to support their initiatives, including the "No Kidney Left Behind" project.

Where is 34 Lives headquartered?

34 Lives is headquartered in the Purdue Research Park in West Lafayette, Indiana.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 304

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 39

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 421

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 212

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 0

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 264

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 264

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Dar Global Eyes Dubai for Strategic Real Estate Moves

Updated Category News Views 0

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 53

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
General Dynamics (GD): Navigating Aerospace Headwinds and Opportunities

Updated Category News Views 209

General Dynamics: Current Market Dynamics General Dynamics Corporation (NYSE: GD) is widely recognized for its pivotal role in the aerospace and defense sectors. The company has a strong reputation, particularly for producing Gulfstream jets, alongside its diverse range of military and marine systems. Despite its established position, General Dynamics has been...

Continue Reading
SunCar Technology Group Inc. Enters NASDAQ Golden Dragon Index

Updated Category News Views 74

SunCar Technology Group Inc. Achieves Milestone Inclusion SunCar Technology Group Inc. (NASDAQ: SDA), a prominent player in the cloud-based B2B automotive services and insurance sector, proudly announces its recent addition to the NASDAQ Golden Dragon China Index. This significant achievement illustrates the company's upward journey and strengthens its market positioning....

Continue Reading
Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 165

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Future Projections: Cosmetic Surgery Market Growth Insights

Updated Category News Views 97

The Expanding Cosmetic Surgery Market The cosmetic surgery market is anticipated to experience significant growth over the coming years, with projections indicating an increase from USD 56.98 billion in 2024 to approximately USD 83.34 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 3.84% from 2024 to 2034, driven by a variety of...

Continue Reading